- 2014
-
Press releases - 02.01.2014
Molecule discovered that protects the brain from cannabis intoxication
Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 “Neurocentre Magendie” in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.
- 2013
-
News in brief - 17.12.2013
Escaping the adverse effects of morphine
Despite its beneficial effects against pain, morphine use is accompanied by adverse effects such as constipation, nausea, vomiting, respiratory depression, and potential dependence on the drug. A research team led by Alain Eschalier, Director of Inserm Unit 1107, Neuro-Dol, in Clermont Ferrand, has just shown that it is possible to separate these two types of […]
-
Press releases - 13.12.2013
A prime target for the development of anti-inflammatories
For the first time, scientists from the Institut Pasteur and Inserm have demonstrated the key role played by a particular molecule in intestinal infection.
-
What's on? - 12.12.2013
Alcohol and research meeting : what is addiction?
4th Meeting-Debate with support groups for people in difficulty with alcohol Are people “addicts” when they are dependent, or is the opposite true? Or are both words totally interchangeable? What is there in common between addiction-dependency on alcohol and dependency-addiction to gambling? The day will be centred around 3 main panel sessions : From alcoholism […]
-
Press releases - 09.12.2013
EUCelLEX Project: assessment of the social issues raised by the use of regenerative medicine in Europe
The European EUCelLEX Project (Cell-based regenerative medicine: new challenges for EU legislation and governance), coordinated by Inserm for a three-year period, funding to the tune of €500,000 from the European Union.
-
What's on? - 05.12.2013
Telethon 2013 : Cure through innovation
“Cure through innovation” is the slogan of the Telethon 2013 fundraising campaign which will begin on 6 and 7 December. For a very long time, these disorders, which are mainly genetic and invalidating, were poorly understood. The Telethon, a major fundraising movement organised by and for the French Muscular Dystrophy Association (AFM), broadcast live on […]
-
What's on? - 02.12.2013
Infanticides : underestimated figures
“The number of infanticides in official statistics is underestimated” says Anne Tursz, Inserm research director, specialist in the mistreatment of children and author of an investigation on suspicious infant deaths. For five years, in all the départements of three French regions, she recorded all deaths that had been referred to the State Prosecutor and all […]
-
Press releases - 02.12.2013
A new Associated International Laboratory on the trail of an ‘electronic nose’ to sniff out Pulmonary Hypertension
Professor André Syrota, Inserm Chief Executive, and Professor Peretz Lavie, President of Technion, will sign the agreement to create a new Associated International Laboratory (AIL) on 17 December 2013. This artificial ‘electronic nose’ project brings together Inserm Unit 999 ‘Pulmonary Hypertension’ and the Russell Berrie Nanotechnology Institute Chemical Engineering department, directed by Professor Hossam Haick.
-
Press releases - 28.11.2013
Maternal mortality: a reduction in deaths from haemorrhage
The new report, “Maternal Mortality in France,” coordinated by Inserm Unit U953, Epidemiological Research Unit on Perinatal Health and Women’s and Children’s Health, announces a reduction in the rate of mortality due to postpartum haemorrhage—the leading cause of maternal mortality in France—for the 2007-2009 data compared to 2004-2006.
-
Press releases - 28.11.2013
Clinical trial launched to treat Sanfilippo B syndrome using gene therapy
A phase I/II gene therapy clinical trial for children suffering from Sanfilippo B syndrome, a rare genetic disease, enrolled a first patient in October of this year.